05
Pharmaceutical preparations for gene therapy; pharmaceutical
preparations, namely, nucleic acid therapeutics for the
treatment of genetic disorders, immune system related
diseases and disorders, metabolic diseases and disorders,
hematological diseases and disorders, cancer, neurological
diseases and disorders, reproductive diseases and disorders,
gynecological diseases and disorders, inflammatory diseases
and disorders, cardiological diseases and disorders,
respiratory diseases and disorders, gastroenterological
diseases and disorders, musculoskeletal diseases and
disorders, ophthalmological diseases and disorders, and
dermatological diseases and disorders; pharmaceutical
preparations, namely, RNA therapeutics for the treatment of
genetic disorders, immune system related diseases and
disorders, metabolic diseases and disorders, hematological
diseases and disorders, cancer, neurological diseases and
disorders, reproductive diseases and disorders,
gynecological diseases and disorders, inflammatory diseases
and disorders, cardiological diseases and disorders,
respiratory diseases and disorders, gastroenterological
diseases and disorders, musculoskeletal diseases and
disorders, ophthalmological diseases and disorders, and
dermatological diseases and disorders
42
Testing, inspection, research, and development of
pharmaceutical preparations for gene therapy
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen